BRCA1 is a component of the RNA polymerase II holoenzyme.
暂无分享,去创建一个
R. Young | D. Livingston | J. Parvin | D. Chao | R. Scully | D M Livingston | L. Ye | J D Parvin | R A Young | R Scully | W Wei | S F Anderson | D M Chao | L Ye | W. Wei | Liyan Ye | S. Anderson | S. Anderson | Wanjiang Wei | R. Young | R. Young
[1] R. Young,et al. General requirement for RNA polymerase II holoenzymes in vivo. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[2] R. Roeder,et al. Cooperative interaction of an initiator-binding transcription initiation factor and the helix–loop–helix activator USF , 1991, Nature.
[3] A. Barberis,et al. Gene activation by recruitment of the RNA polymerase II holoenzyme. , 1996, Genes & development.
[4] E. Lees,et al. Cyclin C/CDK8 is a novel CTD kinase associated with RNA polymerase II. , 1996, Oncogene.
[5] M. Gerritsen,et al. CREB-binding protein/p300 are transcriptional coactivators of p65. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[6] R. Young,et al. RNA Polymerase II Holoenzyme Contains SWI/SNF Regulators Involved in Chromatin Remodeling , 1996, Cell.
[7] Pamela Reinagel,et al. Contact with a component of the polymerase II holoenzyme suffices for gene activation , 1995, Cell.
[8] Yonghong Xiao,et al. Association of BRCA1 with Rad51 in Mitotic and Meiotic Cells , 1997, Cell.
[9] M. Skolnick,et al. BRCA1 mutations in primary breast and ovarian carcinomas. , 1994, Science.
[10] U. Schibler,et al. A mammalian RNA polymerase II holoenzyme containing all components required for promoter-specific transcription initiation , 1995, Cell.
[11] Danny Reinberg,et al. A human RNA polymerase II complex associated with SRB and DNA-repair proteins , 1996, Nature.
[12] J. Direnzo,et al. p300 is a component of an estrogen receptor coactivator complex. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[13] H. Hanafusa,et al. Evidence for a transcriptional activation function of BRCA1 C-terminal region. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[14] E. Kieff,et al. Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappa , 1995, Journal of virology.
[15] M. King,et al. Inherited breast and ovarian cancer. , 1995, Human molecular genetics.
[16] I. Verma,et al. Transcriptional activation by BRCA1 , 1996, Nature.
[17] Richard A. Young,et al. An RNA polymerase II holoenzyme responsive to activators , 1994, Nature.
[18] S. Bhattacharya,et al. Cooperation of Stat2 and p300/CBP in signalling induced by interferon-α , 1996, Nature.
[19] Thomas Shenk,et al. YY1 is an initiator sequence-binding protein that directs and activates transcription in vitro , 1991, Nature.
[20] E. Nigg,et al. Identification of human cyclin-dependent kinase 8, a putative protein kinase partner for cyclin C. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[21] Yang Li,et al. A multiprotein mediator of transcriptional activation and its interaction with the C-terminal repeat domain of RNA polymerase II , 1994, Cell.
[22] S. Neuhausen,et al. Loss of heterozygosity in familial tumors from three BRCA1-linked kindreds. , 1994, Cancer Research.
[23] S. F. Anderson,et al. A mammalian SRB protein associated with an RNA polymerase II holoenzyme , 1996, Nature.
[24] R. Young,et al. A kinase–cyclin pair in the RNA polymerase II holoenzyme , 1995, Nature.
[25] E. Moran,et al. Relief of YY1 transcriptional repression by adenovirus E1A is mediated by E1A-associated protein p300. , 1995, Genes & development.
[26] Steven E. Bayer,et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.
[27] C. Osborne,et al. Location of BRCA1 in Human Breast and Ovarian Cancer Cells , 1996, Science.
[28] S. F. Anderson,et al. Analysis of a cAMP-responsive activator reveals a two-component mechanism for transcriptional induction via signal-dependent factors. , 1997, Genes & development.
[29] D. Easton,et al. Allele losses in the region 17q12–21 in familial breast and ovarian cancer involve the wild–type chromosome , 1992, Nature Genetics.
[30] P. Sharp,et al. In vitro transcription: whole-cell extract. , 1983, Methods in enzymology.
[31] N. Thompson,et al. Purification of eukaryotic RNA polymerase II by immunoaffinity chromatography. Elution of active enzyme with protein stabilizing agents from a polyol-responsive monoclonal antibody. , 1990, The Journal of biological chemistry.
[32] M. Montminy,et al. Role of CBP/P300 in nuclear receptor signalling , 1996, Nature.